TetraLogic Pharmaceuticals Long Term Debt

TetraLogic Pharmaceuticals (TLOG) currently reports a long-term debt of $31M as of September 2016. That compares with $29M in the prior-year period — up 6.9% year over year. Use the charts on this page to explore TetraLogic Pharmaceuticals's long-term debt history and peer comparisons.

TetraLogic Pharmaceuticals's long-term debt increased from $29M to $31M — a 6.9% year-over-year increase (period ending September 2016). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

TetraLogic Pharmaceuticals reported $31M in long-term debt as of September 2016. That compares with $29M in the prior-year period — up 6.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $31M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for TetraLogic Pharmaceuticals, and consider following TLOG for alerts when major investors trade the stock.

TetraLogic Pharmaceuticals is classified in the Healthcare sector. On long-term debt, it currently shows $31M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TLOG with unrelated industries.